INTRODUCTION
============

Bacteria and other microorganisms are exposed to various stressful conditions, including nutrient limitation or physical stress, in their natural environment. In such conditions, many of bacteria tend to convert into the stationary phase or dormant state in order to endure long-term nutrient limitation and starvation ([@b31-molcell-37-10-719]; [@b33-molcell-37-10-719]). However, other bacteria that have not developed starvation-resistance require a supply of energy for survival, obtained by amino acid utilization and progressive protein synthesis ([@b31-molcell-37-10-719]). The γ-Aminobutyric acid (GABA) is synthesized from glutamate by glutamate decarboxylase, and is a non-protein amino acid found in virtually all prokaryotic and eukaryotic organisms ([@b3-molcell-37-10-719]). GABA is used for various roles, including as a signaling molecule or as a significant component for generating metabolic energy under conditions of nutrient limitation or stress ([@b12-molcell-37-10-719]). GABA catabolism involves a two-step pathway, and the product is introduced into the tricarboxylic acid (TCA) cycle in the form of succinic acid (SA). In the first step of GABA catabolism, GABA transaminase converts GABA to succinic semialdehyde (SSA). Then, SSA is oxidized by succinic semialdehyde dehydrogenase (SSADH) to SA in the presence of NAD(P)^+^ ([@b29-molcell-37-10-719]).

SSADH, which is the enzyme in the final step of GABA catabolism, belongs to the aldehyde dehydrogenases (ALDHs) super-family, and has strict substrate specificity that uses only SSA as the substrate ([@b9-molcell-37-10-719]). Deficiency of SSADH causes rare autosomal recessive disease in humans, and similarly, causes various developmental and phenotypic changes in plants ([@b4-molcell-37-10-719]; [@b9-molcell-37-10-719]; [@b19-molcell-37-10-719]). In bacteria, SSADHs play important roles in metabolism, including in the detoxification of accumulated SSA, and survival under limited nutrient conditions ([@b13-molcell-37-10-719]; [@b29-molcell-37-10-719]). *Escherichia coli* has two genes, *gabD* and *yneI* (also called *sad*), encoding different SSADHs. While the *gabD* gene encodes an NADP^+^-dependent SSADH (GabD), the SSADH encoded by the *yneI* gene (YneI) can use either NAD^+^ or NADP^+^ as a cofactor ([@b13-molcell-37-10-719]; [@b36-molcell-37-10-719]).

The gram-positive human pathogen *Streptococcus pyogenes* causes numerous diseases ranging from mild upper respiratory tract and skin infections (e.g. pharyngitis and pyoderma) to extremely severe infections (e.g. streptococcal toxic syndrome and necrotizing fasciitis) ([@b8-molcell-37-10-719]; [@b26-molcell-37-10-719]). *S. pyogenes* shows characteristics of persistent infection, such as asymptomatic carriage and failure of antibiotic treatment ([@b15-molcell-37-10-719]; [@b33-molcell-37-10-719]). During persistent infection, *S. pyogenes* adapts to a variety of environmental conditions by expression changes in the growth phase-associated genes ([@b6-molcell-37-10-719]; [@b7-molcell-37-10-719]; [@b32-molcell-37-10-719]). These changes are mediated by appropriate mechanisms, including amino acid utilization and the use of alternative nutrient sources, as required for survival or virulence ([@b7-molcell-37-10-719]; [@b33-molcell-37-10-719]).

To date, crystal structures of several SSADHs have been reported ([@b2-molcell-37-10-719]; [@b18-molcell-37-10-719]; [@b21-molcell-37-10-719]; [@b24-molcell-37-10-719]; [@b35-molcell-37-10-719]; [@b36-molcell-37-10-719]). However, structural information on bacterial SSADHs remains poorly studied in comparison to other dehydrogenases, with regard to their cofactor preferences and distinct dimeric or tetrameric forms. Thus, more detailed investigations are required for comparison with existing SSADH structures, and to improve our understanding of their metabolic functions. Here, we present the cofactor preference and two crystal structures in an apo-form and in a binary complex with NADP^+^ of gram-positive bacterial SSADH from *S. pyogenes* (SpSSADH). The analysis of kinetic parameters showed that SpSSADH could be classified as an ortholog of GabD, using NADP^+^ as the preferred hydride acceptor. Moreover, both structures showed dimeric conformation, unlike the tetrameric structure exhibited by *E. coli* and human SSADHs. The complex structure of SpSSADH with NADP^+^ showed cofactor discriminative recognition by means of several polar residues, which interacted with the 2'-phosphate group of adenine-side ribose in NADP^+^. Our results provide kinetic and molecular insightful information regarding the cofactor preference of SpSSADH.

MATERIALS AND METHODS
=====================

Preparation of SpSSADH enzyme
-----------------------------

The expression and purification of SpSSADH were performed as previously described ([@b17-molcell-37-10-719]). Briefly, the gene encoding SpSSADH was amplified by PCR from *S. pyogenes* genomic DNA, and the amplified DNA fragment was cloned into the pET-28a vector (Novagen) with a His~6~ tag. Then, recombinant plasmids were transformed into *E. coli* BL21 (DE3) strain (Novagen). The expressed SpSSADH enzyme was purified using immobilized metal ion affinity chromatography and size-exclusion chromatography. Sequentially, purified enzyme was concentrated to 26 mg ml^−1^ and stored at −80°C. The enzyme concentration was estimated using the Bradford assay, and the molarity of active enzyme was determined by cysteine titration at the unfolded state using 5,5'-dithio*bis*(2-nitrobenzoate) (Sigma) ([@b34-molcell-37-10-719]).

Enzyme assay for cofactor preference
------------------------------------

The enzyme activities of purified SpSSADH by varying concentrations of both NAD^+^ and NADP^+^ were determined by monitoring the increase of absorbance at UV 340 nm (ε~340~ 6.22 mM^−1^ cm^−1^), resulting from the conversion of NAD(P)^+^ to NAD(P)H. The reaction mixtures (1.0 ml), containing 20 mM Tris-HCl (pH 7.0) and 5.0 mM DTT, were pre-incubated with 0.5 mM SSA and various concentrations of NAD(P)^+^ (0.05--1.2 mM) at 30°C for 5 min. Then, the reaction was initiated by adding of SpSSADH (1 μg/ml, 0.0393 μM). The initial velocities were estimated from the initial linear portion for the time-courses. All the reactions were performed in triplicate. The kinetic parameters for cofactor preference were determined by nonlinear least-squares fitting to the standard Michaelis-Menten equation and were confirmed with double-reciprocal plots of the initial velocities obtained at varied NAD(P)^+^ concentrations using *SigmaPlot* (ver. 10.0).

Crystallization and X-ray diffraction data collection
-----------------------------------------------------

Prepared SpSSADH enzyme was crystallized by the hanging-drop vapor diffusion method at 22°C. Each hanging drop was prepared by mixing 1 μl protein solution and 1 μl reservoir solution, and was equilibrated over a 500 μl reservoir solution. The crystals of apo-SpSSADH were obtained in reservoir solution containing 0.1 M MES monohydrate (pH 5.8--6.1) and 18--23% (w/v) PEG 4000 ([@b17-molcell-37-10-719]). For co-crystallization with NADP^+^, the protein solution was mixed with NADP^+^ in a 1:10 molar ratio. The crystals of SpSSADH-NADP^+^ complex were obtained in a buffer consisting of 0.1 M sodium acetate trihydrate (pH 4.6) and 2 M ammonium sulfate.

For cryogenic experiments, both crystals were transferred into a cryoprotection solution consisting of 25% (v/v) ethylene glycol in reservoir solution, and were flash-frozen in a stream of nitrogen gas. X-ray diffraction data of SpSSADH crystals in an apo-form and in a binary complex with NADP^+^ were collected on a beamline BL26B1 at SPring-8 (Hyogo, Japan) using a Rigaku/MSC Jupiter 210 CCD detector, and on a beamline 5C at the Pohang Light Source (Korea) using an ADSC Quantum 315r CCD detector, respectively. The diffraction data were collected at the resolution of 1.6 Å for apo-crystals, and 2.1 Å for NADP^+^ complex crystals. All data sets were indexed, integrated and scaled using *HKL-2000* software package ([@b23-molcell-37-10-719]).

Structure determination and refinement
--------------------------------------

The crystal structure was solved by the molecular-replacement (MR) method using *CNS* program ([@b5-molcell-37-10-719]) with the structure of *E. coli* SSADH (EcSSADH, PDB ID 3JZ4) ([@b21-molcell-37-10-719]) as the search model. The SpSSADH crystals in an apo-form and in a binary complex with NADP^+^ belonged to the orthorhombic *P*2~1~2~1~2~1~ and tetragonal *P*4~3~2~1~2 space groups, respectively. The structural refinement was performed with *PHENIX* program ([@b1-molcell-37-10-719]), and the model was rebuilt with *COOT* ([@b11-molcell-37-10-719]). The final model of the apo-structure contained one dimer, and the final *R*~factor~ and *R*~free~ values were 17.4% and 19.9%, respectively. The refined apo-form structure was then used as an initial model to solve the structure of the binary complex. Structural refinements of the binary complex were performed using a rigid body refinement, followed by a simulated annealing refinement. The final model of the NADP^+^ complex structure was determined using *CNS* program ([@b5-molcell-37-10-719]), and also contained one dimer with a single NADP^+^ per subunit, and the final *R*~factor~ and *R*~free~ values were 20.1% and 22.4%, respectively. Structural validations of both structures were analyzed using *PROCHECK* program ([@b22-molcell-37-10-719]), and no residue was detected in the disallowed region of the Ramachandran plot ([@b27-molcell-37-10-719]). The data collection and final refinement statistics are summarized in [Table 1](#t1-molcell-37-10-719){ref-type="table"}. All structural figures were prepared using *PyMOL* ([@b30-molcell-37-10-719]).

Protein data bank accession number
----------------------------------

The atomic coordinates and structure factors of the apo-form and the binary complex structures have been deposited in the Protein Data Bank (<http://www.rcsb.org/pdb>) with accession numbers 4OGD and 4OHT, respectively.

RESULTS AND DISCUSSION
======================

Catalytic properties of SpSSADH by cofactor preference
------------------------------------------------------

Although SSADHs from various species have been classified as GabD and YneI, depending on the cofactor preference that is utilized either NADP^+^ or NAD^+^, their catalytic efficiencies have shown various differences between each cofactors. In the case of GabD, the EcSSADH has been reported to allow both NADP^+^ and NAD^+^ as cofactors, but its activity with NADP^+^ was more than 20-fold higher than that with NAD^+^ ([@b16-molcell-37-10-719]). Moreover, *Drosophila melanogaster* MalE-DmSSADH showed 7-fold higher activity in the presence of NAD^+^ than NADP^+^ ([@b28-molcell-37-10-719]). On the other hand, in the case of YneI, the SSADHs from *Bacillus subtilis* ([@b25-molcell-37-10-719]) and *Salmonella typhimurium* ([@b36-molcell-37-10-719]) showed differences in affinity for NAD^+^ or NADP^+^, but their catalytic efficiency exhibited similar values in both cofactors.

To investigate the cofactor preference of SpSSADH, initial velocities were determined by varying the concentration of NAD^+^ or NADP^+^ at a fixed concentration of SSA. The activities of SpSSADH depending on various concentrations of each cofactor followed Michaelis-Menten kinetics ([Fig. 1](#f1-molcell-37-10-719){ref-type="fig"}). The *K*~m~ and *k*~cat~ values for NADP^+^ as the cofactor were approximately 2-fold lower and 4-fold higher than the values for NAD^+^, respectively ([Table 2](#t2-molcell-37-10-719){ref-type="table"}). As a result, SpSSADH showed more than 7-fold higher values of the catalytic efficiency (*k*~cat~/*K*~m~) for NADP^+^ than that for NAD^+^, which were estimated to be 7.2 ± 0.3 × 10^4^ M^−1^s^−1^ and 9.7 ± 0.5 × 10^3^ M^−1^s^−1^, respectively. These results indicate that SpSSADH prefers NADP^+^ over NAD^+^, although it can use both cofactors as the hydride acceptor. Thus, SpSSADH can be classified as an ortholog of GabD, corresponding to an NADP^+^-dependent SSADH.

Overall structure of apo-SpSSADH
--------------------------------

The crystal structure of apo-form SpSSADH was determined at the high resolution of 1.6 Å using the MR method, and showed the two subunits in an asymmetric unit with the crystallographic symmetry of *P*2~1~2~1~2~1~ space group representing the functional unit of the homodimer. Consistent with the structural observation, SpSSADH existed as a dimer in solution, which was characterized by size-exclusion chromatography. The PISA server ([@b20-molcell-37-10-719]) also predicted a dimeric interface with 5,033 Å^2^ of total solvent-accessible buried surface area for this protein.

Analysis of multiple alignments of SpSSADH with other SSADHs showed a low sequence identity of approximately 35% ([Fig. 2A](#f2-molcell-37-10-719){ref-type="fig"}). Despite this low sequence similarity, monomeric SpSSADH is composed of three domains, similar to previously reported SSADH structures ([@b2-molcell-37-10-719]; [@b18-molcell-37-10-719]; [@b21-molcell-37-10-719]; [@b24-molcell-37-10-719]; [@b35-molcell-37-10-719]; [@b36-molcell-37-10-719]): the N-terminal cofactor-binding domain (residues 2--103, 122--230 and 423--446), the catalytic domain (residues 231--422) and the oligomerization domain (residues 104--121 and 447--456) ([Figs. 2A](#f2-molcell-37-10-719){ref-type="fig"} and [2B](#f2-molcell-37-10-719){ref-type="fig"}). Specifically, the catalytic domain consists of a seven-stranded β-sheet (β9-β15) between two α-helices (α8, α9) on one side, and three α-helices (α10-α12) on the other side. The cofactor-binding domain displays two Rossmann folds, with a combination of N-terminal two anti-parallel β-strands (β1, β2) and a central five-stranded parallel β-sheet (β4-β8), surrounded by three α-helices (α1, α6, α7) and four α-helices (α2-α5). Two antiparallel β-strands (β3, β16) constructing the oligomerization domain are stretched across the center of the dimer interface. The catalytic residues, which have been characterized in other SSADHs ([@b2-molcell-37-10-719]; [@b18-molcell-37-10-719]; [@b21-molcell-37-10-719]; [@b24-molcell-37-10-719]; [@b35-molcell-37-10-719]; [@b36-molcell-37-10-719]) are conserved in SpSSADH (Cys263 and Glu229) and are located in the middle of the catalytic and cofactor-binding domains. Cys263, as a nucleophilic attacker, is located in the catalytic loop between α8 and β10 of the catalytic domain, and Glu229, as a general base, is located at the end of β8.

Structure of SpSSADH in a binary complex with NADP^+^
-----------------------------------------------------

To confirm the structural basis for cofactor preference and binding properties of SpSSADH, the binary complex structure of SpSSADH with NADP^+^ was also determined at a resolution of 2.1 Å ([Fig. 3A](#f3-molcell-37-10-719){ref-type="fig"}). The overall structure of the binary complex was very similar to the apo-structure, with a root mean square deviation of 0.73 Å. In the binary complex structure of SpSSADH, the adenine moiety of NADP^+^ molecule was determined to be in the form of 2′-monophosphoadenosine-5′-diphosphate (2′P-ADP, PubChem ID 165230), using a well-defined electron density map ([Fig. 3B](#f3-molcell-37-10-719){ref-type="fig"}). However, the nicotinamide ring portion of NADP^+^ could not be modeled, due to the absence of electron density. Similar phenomena that the nicotinamide ring and linked ribose portions of the cofactor are flexible enough to generate a poor electron density map have been reported in human SSADH (HsSSADH) and other ALDHs ([@b10-molcell-37-10-719]; [@b18-molcell-37-10-719]).

The partial NADP^+^ in the binary complex is located between α6 and α7 in the cofactor-binding domain, and is stabilized by hydrogen bonds with neighboring residues ([Fig. 3B](#f3-molcell-37-10-719){ref-type="fig"}). The nitrogen atom on the edge of the adenine base is hydrogen bonded with the side chain of Ser214. The 2′-phosphate group of ribose is stabilized by hydrogen bonds with the side chains of Lys155, Ser158 and Tyr188. In particular, three residues are considered to contribute to the cofactor selection of NADP^+^ ([Fig. 3C](#f3-molcell-37-10-719){ref-type="fig"}). The main chain of Glu129 forms a hydrogen bond with the 3′-hydroxyl group of ribose. The pyrophosphate group of the cofactor maintains only a few hydrogen bonds with the side chains of Trp131 and Ser208. In addition to the hydrogen bond forming residues, the adenine base is inserted into a hydrophobic pocket formed by several residues, including Val128, Val191, Leu205 and Ile215.

Structural comparison of SpSSADH with other SSADHs
--------------------------------------------------

Structural comparison of SpSSADH was performed by superimposition with the structures of SSADHs from human ([@b18-molcell-37-10-719]), *E. coli* ([@b2-molcell-37-10-719]; [@b21-molcell-37-10-719]) and *Synechococcus* (SySSADH) ([@b24-molcell-37-10-719]; [@b35-molcell-37-10-719]). Although the monomeric structure of SpSSADH was quite similar to other SSADHs involving the cofactor- and substrate-binding sites, SpSSADH showed a dimeric interface, unlike the tetrameric structure exhibited by EcSSADH and HsSSADH. Another significant feature of SpSSADH is the presence of a single cysteine residue (Cys263) at the catalytic loop ([Fig. 4](#f4-molcell-37-10-719){ref-type="fig"}), which is similar to most members of the ALDH family ([@b24-molcell-37-10-719]). HsSSADH contains paired cysteine residues (Cys340 and Cys342) for disulfide bond formation, but the position of the partner cysteine in SpSSADH is replaced by Ser265. Thus, redox-switch modulation proposed in HsSSADH is not applicable in SpSSADH. Moreover, the active site of SpSSADH contains the catalytic residues (Cys263 and Glu229) and several conserved residues (Arg140 and Ser420) that are involved in substrate stabilization in other SSADHs.

For structure-based confirmation of the cofactor preference, the binding of NADP^+^ in the binary complex of SpSSADH was compared with the structures of HsSSADH ([Fig. 5A](#f5-molcell-37-10-719){ref-type="fig"}) and SySSADH ([Fig. 5B](#f5-molcell-37-10-719){ref-type="fig"}) in complexes with their cofactors. Although the binary complex structure of SpSSADH contained a partial NADP^+^, the structural superimposition of SpSSADH with other SSADHs revealed that the adenine moiety of NADP^+^ was located at almost the identical position of the cofactor-binding site. In addition, the residues forming hydrogen bonds with the adenine moiety of NADP^+^ in SpSSADH are mostly conserved in other SSADHs, and located at similar positions to corresponding residues. Previous studies on the structure of SySSADH have suggested that the particular residue in the cofactor-binding site plays an important role in selective recognition of the cofactor ([@b24-molcell-37-10-719]; [@b35-molcell-37-10-719]). For example, a polar residue with short side chain, such as serine or threonine, in the cofactor-binding pocket permits NADP^+^ rather than NAD^+^, whereas a residue with negative-charged long side chain, such as glutamate, prefers NAD^+^ ([@b35-molcell-37-10-719]). Interestingly, the binary complex structure of SpSSADH with NADP^+^ shows that Ser158 is located at the critical position for cofactor recognition, while HsSSADH contains Glu231 residue in this position ([Fig. 5A](#f5-molcell-37-10-719){ref-type="fig"}). This result implies that SpSSADH prefers NADP^+^ rather than NAD^+^ as a cofactor, which is consistent with the NADP^+^-binding SSADHs from *E. coli* and *Synechococcus* containing Ser182 and Ser157, respectively.

In the different structural features inferring the NADP^+^-binding properties of SpSSADH ([Fig. 5B](#f5-molcell-37-10-719){ref-type="fig"}), the 2′-phosphate group of adenine-side ribose in NADP^+^ is further stabilized by hydrogen bond with the side chain of Tyr188, which is not found in EcSSADH (Gly213) or SySSADH (Ala187). As shown in [Fig. 3B](#f3-molcell-37-10-719){ref-type="fig"}, the hydrogen bond in the corresponding interaction with Tyr188 (2.50 Å) is formed at a closer distance than that of Ser158 (3.51 Å), which is the key residue for the cofactor discrimination. Additionally, the value of *K*~m~ for NADP^+^ (0.10 ± 0.01 mM) of SpSSADH was approximately 2-fold lower than that for NAD^+^ (0.23 ± 0.02 mM), as described in the analysis of kinetic parameters, and was also 4-fold lower than that for NADP^+^ of SySSADH (0.44 mM) ([@b24-molcell-37-10-719]). Thus, we assume that Tyr188 of SpSSADH may contribute not only facilitating the corresponding binding of either NADP^+^ or NAD^+^, but also enhancing the binding affinity of NADP^+^ particularly, although further studies remain to elucidate its function. Apart from this, the residues, Asn132, Arg140 and Leu230, located at the entrance of the active site in SpSSADH, are conserved as the cofactor-binding residues forming hydrogen bonds with the nicotinamide moiety of NADP^+^ in other SSADHs.
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![SpSSADH activity by cofactor preference. Plots of the initial velocity as a function of cofactor concentration are shown for NAD^+^ (closed circles) and NADP^+^ (open circles). The reaction mixtures containing 0.5 mM SSA and 0.05--1.2 mM NAD(P)^+^ were pre-incubated at 30°C for 5 min. The reaction was initiated by adding of SpSSADH (1 μg/ml, 0.0393 μM).](molcell-37-10-719f1){#f1-molcell-37-10-719}

![Sequence alignment and overall structure of SpSSADH. (A) Amino acid sequence alignment of SpSSADH with other SSADHs. SpSSADH, HsSSADH, EcSSADH and SySSADH are representations of *Streptococcus pyogenes* SSADH (GI: 383493878), human SSADH (GI: 3766467), *E. coli* SSADH (GI: 120777) and *Synechococcus* SSADH (GI: 170079362), respectively. Secondary structure elements are drawn on the basis of SpSSADH structure and shown with helices (α-helix) and arrows (β-strand) at the top of the aligned sequences. Strictly conserved residues are shown with white characters on a red background, and highly similar residues are shown in red characters with blue frames. The catalytic residues and the residues involved in stabilization of the 2′-phosphate group of adenine-side ribose in NADP^+^ are indicated by squares at the bottom of the sequences with green and orange colors, respectively. This figure was prepared using *ESPript* ([@b14-molcell-37-10-719]). (B) Overall structure of SpSSADH dimer. The catalytic domain, the cofactor-binding domain and the oligomerization domain of one subunit are colored in blue, orange and green, respectively. Secondary structure elements are labeled on the corresponding sites in the monomeric structure.](molcell-37-10-719f2){#f2-molcell-37-10-719}

![Binary complex structure of SpSSADH. (A) Overall structure of SpSSADH dimer with partial NADP^+^. Each subunit of the binary complex are shown in blue and pink, respectively. The adenine moiety of NADP^+^ in a form of 2′P-ADP is located at the cofactor-binding domain per each subunit, and represented by stick model in green. (B) Cofactor-binding site of SpSSADH. The NADP^+^ binding site of SpSSADH is shown in orange by cartoon model. The SpSSADH residues forming hydrogen bonds with NADP^+^ are shown as stick model in cyan. The bound NADP^+^, in the form of 2′P-ADP, is represented by stick model in green with omitted 2*F*~o~--*F*~c~ electron density map at 1.0 σ (blue mesh). The hydrogen bond interactions are displayed with black dotted lines with the distances. (C) Surface model for the cofactor-binding pocket of SpSSADH. The bound NADP^+^, in the form of 2′P-ADP, is shown in green-colored stick model. The SpSSADH residues involved in stabilization of the 2′-phosphate group of ribose in NADP^+^ are highlighted in cyan.](molcell-37-10-719f3){#f3-molcell-37-10-719}

![Stereo view of superimposed structures at the active site. The active site of apo-form SpSSADH structure (cyan) is compared with HsSSADH (PDB ID 2W8O, orange), EcSSADH (PDB ID 3JZ4, blue) and SySSADH (PDB ID 4ITA, pink). The catalytic and conserved residues of SpSSADH are shown as stick model in cyan and labeled in black characters, whereas the corresponding residues of other SSADHs are shown in transparent gray stick model. The Ser265 residue of SpSSADH is shown at the position of the partner cysteine residue in HsSSADH (Cys342), which forms a disulfide bond with the catalytic cysteine.](molcell-37-10-719f4){#f4-molcell-37-10-719}

![Structural comparison of SpSSADH at the cofactor-binding site. (A) Stereo view of the superimposition of SpSSADH binary complex with NAD^+^-binding HsSSADH structure (PDB ID 2W8R). Superimposed structures of SpSSADH and HsSSADH are shown in cyan- and orange-colored cartoon model, respectively. The partial NADP^+^ (2′P-ADP) bound to SpSSADH is shown as stick model in green, and the ADP moiety of NAD^+^ in HsSSADH structure is shown in transparent gray. The residues of SpSSADH involved in the stabilization of NADP^+^ are shown in cyan by stick model, whereas the corresponding residues of HsSSADH are shown in transparent gray. The residues with black characters are labeled on the basis of SpSSADH. The residue of HsSSADH (Glu231) corresponding to the cofactor preference determining residue is labeled in parentheses. (B) Stereo view of superimposition of the SpSSADH binary complex with the NADP^+^-binding SySSADH structure (PDB ID 3VZ3). Superimposed structures of SpSSADH and SySSADH are shown in cyan- and pink-colored cartoon model, respectively. The partial NADP^+^ (2′P-ADP) bound to SpSSADH is shown in green by stick model, and the NADP^+^ in the SySSADH structure is shown in transparent gray. The residues of SpSSADH, which are conserved in SySSADH and involved in cofactor stabilization, are shown in cyan-colored stick model, whereas the corresponding residues of SySSADH are represented in transparent gray. The residues with black characters are labeled on the basis of SpSSADH. The residue of SySSADH (Ala187) corresponding to Tyr188 of SpSSADH, which is involved in the stabilization of the 2′-phosphate group of adenine-side ribose in NADP^+^, is labeled in parentheses.](molcell-37-10-719f5){#f5-molcell-37-10-719}

###### 

Data collection and refinement statistics of SpSSADH

  PDB ID                                                                     Apo 4OGD                                  NADP^+^ complex 4OHT
  -------------------------------------------------------------------------- ----------------------------------------- ------------------------------------------
  Data collection                                                                                                      
    Space group                                                              *P*2~1~2~1~2~1~                           *P*4~3~2~1~2
    Wavelength (Å)                                                           1.0000                                    0.97951
    Cell dimensions (Å)                                                      *a* = 93.26, *b* = 100.28, *c* = 105.10   *a* = 134.76, *b* = 134.76, *c* = 173.53
    Resolution range (Å)                                                     50.0--1.6 (1.63--1.60)                    50.0--2.1 (2.18--2.10)
    Total reflections                                                        1,262,499                                 837,575
    Unique reflections                                                       128,443                                   93,776
    Completeness (%)                                                         98.5 (88.4)                               99.4 (98.7)
    R~merge~[^a^](#tfn2-molcell-37-10-719){ref-type="table-fn"} (%)          7.1 (30.6)                                12.6 (44.1)
    Redundancy                                                               9.8 (4.8)                                 8.9 (5.9)
    *I*/*σ*(*I*)                                                             26.3 (2.5)                                21.5 (3.7)
  Refinement                                                                                                           
    Resolution range (Å)                                                     18.0--1.6                                 39.9--2.1
    *R* / *R*~free~[^b^](#tfn3-molcell-37-10-719){ref-type="table-fn"} (%)   17.4/19.9                                 20.1/22.4
    No. of atoms                                                                                                       
      Protein                                                                7,148                                     7,148
      Water                                                                  527                                       614
      NADP^+^                                                                \-                                        62
    Average *B*-factors                                                                                                
      Protein (Å^2^)                                                         13.2                                      35.9
      Ligand (Å^2^)                                                          \-                                        53.3
      Water (Å^2^)                                                           16.3                                      47.7
    *RMS* deviations                                                                                                   
      Bond length (Å)                                                        0.006                                     0.010
      Bond angle (°)                                                         1.033                                     1.200
    Ramachandran plot                                                                                                  
      Favored (%)                                                            99.4                                      99.5
      Allowed (%)                                                            0.6                                       0.5
      Disallowed (%)                                                         0                                         0

Values in parentheses indicate data of the highest resolution shell.

*R*~merge~ = Σ\|*I*~h~--\<*I*~h~ \>\|/Σ *I*~h~, where *I*~h~ represents the observed intensity and \<*I*~h~\> is the average intensity.

*R* = Σ‖*F*~obs~\|--\|*F*~calc~‖ /Σ\|*F*~obs~\|, where \|*F*~obs~\| and \|*F*~calc~\| represent the observed and calculated structure factor amplitudes, respectively.

*R*~free~ is calculated for a randomly chosen 5% of reflections, which were not used during refinement calculations.

###### 

Steady-state kinetic parameters of SpSSADH

  Variable ligand   Fixed substrate   *K*~m~ (mM)   *k*~cat~ (s^−1^)   *k*~cat~/*K*~m~ (M^−1^s^−1^)   *R*^2^[\*](#tfn5-molcell-37-10-719){ref-type="table-fn"}
  ----------------- ----------------- ------------- ------------------ ------------------------------ ----------------------------------------------------------
  NAD^+^            SSA (0.5 mM)      0.23 ± 0.02   1.94 ± 0.08        9.7 ± 0.5 × 10^3^              0.9952
  NADP^+^           SSA (0.5 mM)      0.10 ± 0.01   7.20 ± 0.12        7.2 ± 0.3 × 10^4^              0.9974

*R*^2^ = Coefficient of determination
